ArticleJournal of cachexia, sarcopenia and muscle2016
Unlocking the wasting enigma: Highlights from the 8th Cachexia Conference.
Article in Journal of cachexia, sarcopenia and muscle, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.
- Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review.Journal of cachexia, sarcopenia and muscle · 2019Pooled it
- Cancer-Associated Cachexia in the Era of Obesity.International journal of molecular sciences · 2025Review
- Evaluation of Computationally Designed Peptides against TWEAK, a Cytokine of the Tumour Necrosis Factor Ligand Family.International journal of molecular sciences · 2021Article
- Emerging molecular mediators and targets for age-related skeletal muscle atrophy.Translational research : the journal of laboratory and clinical medicine · 2020Review
- Pharmacological targeting of age-related changes in skeletal muscle tissue.Pharmacological research · 2020Review
- Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 12th Cachexia Conference.Journal of cachexia, sarcopenia and muscle · 2020Article
- Cardiac Cachexia: A Well-Known but Challenging Complication of Heart Failure.Clinical interventions in aging · 2020Review
- Anabolism to Catabolism: Serologic Clues to Nutritional Status in Heart Failure.Current heart failure reports · 2019Review
- Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 11th Cachexia Conference.Journal of cachexia, sarcopenia and muscle · 2019Article
- Muscle Wasting Diseases: Novel Targets and Treatments.Annual review of pharmacology and toxicology · 2019Review
- Nutritional Considerations of Cardiovascular Diseases and Treatments.Nutrition and metabolic insights · 2019Review
- Metabolic disorders in heart failure and cancer.ESC heart failure · 2018Review
- Skeletal muscle wasting in chronic heart failure.ESC heart failure · 2018Review
- Muscle wasting and sarcopenia in heart failure: a brief overview of the current literature.ESC heart failure · 2018Article
- Klebsiella oxytoca expands in cancer cachexia and acts as a gut pathobiont contributing to intestinal dysfunction.Scientific reports · 2018Article
- [Cachexia and sarcopenia in chronic heart failure : Change in muscle strength and muscle structure].Der Internist · 2018Review
- Article
- Silver linings on the horizon: highlights from the 10th Cachexia Conference.Journal of cachexia, sarcopenia and muscle · 2018Article
- Research priorities in cancer cachexia: The University of Rochester Cancer Center NCI Community Oncology Research Program Research Base Symposium on Cancer Cachexia and Sarcopenia.Current opinion in supportive and palliative care · 2017Review
- Casting the net broader to confirm our imaginations: the long road to treating wasting disorders.Journal of cachexia, sarcopenia and muscle · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This article highlights pre-clinical and clinical studies into the field of wasting disorders that were presented at the 8th Cachexia Conference held in Paris, France December 2015. This year some interesting results of clinical trials and different new therapeutic targets were shown. This article presents the biological and clinical significance of different markers and new drugs for the treatment of skeletal muscle wasting. Effective treatments of cachexia and wasting disorders are urgently needed in order to improve the patients' quality of life and their survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.